Tadalafil
NDC 67184-0525, Tadalafil, tablet, film coated, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0525
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210420
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0525 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TADALAFIL10 mg/1
Pharmacologic classes
Phosphodiesterase 5 Inhibitor [EPC]; Phosphodiesterase 5 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0525-2 | 67184052502 | 1 BLISTER PACK in 1 CARTON (67184-0525-2) / 7 TABLET, FILM COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/f295f164-78fb-4224-b319-9f20b7a453b5
Use it
Look up 67184-0525 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0525 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0525. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.